A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a study designed to evaluate the efficacy and safety of lurasidone in acutely psychotic patients with chronic schizophrenia and to confirm the non-inferiority of lurasidone relative to quetiapine XR.
Epistemonikos ID: d36ca98e23ca28e6fd1ff0991fa6c736b23bc9f4
First added on: May 21, 2024